What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Cancer research, Biochemistry, Pharmacology, Structure–activity relationship and PKM2.
His Cancer research research includes themes of Diffuse large B-cell lymphoma, Signal transduction, breakpoint cluster region, B-cell receptor and Bruton's tyrosine kinase.
His work on Small molecule, Enzyme, Thioredoxin and Chinese hamster ovary cell as part of general Biochemistry study is frequently connected to Peroxiredoxin, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His Drug study, which is part of a larger body of work in Pharmacology, is frequently linked to Esketamine, bridging the gap between disciplines.
His biological study spans a wide range of topics, including Camptothecin, DNA, Beta-Lactamase Inhibitors, DNA Topoisomerase I and High-throughput screening.
He has included themes like Cancer cell, Enzyme activator and Pyruvate decarboxylation in his PKM2 study.
His most cited work include:
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma (1127 citations)
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites (770 citations)
- Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses (755 citations)
What are the main themes of his work throughout his whole career to date?
Craig J. Thomas focuses on Cancer research, Pharmacology, Biochemistry, Stereochemistry and Kinase.
The various areas that he examines in his Cancer research study include Cancer cell, Cancer, Carcinogenesis, Cell growth and PI3K/AKT/mTOR pathway.
His work in Pharmacology addresses issues such as Ketamine, which are connected to fields such as Hydroxynorketamine.
His studies in Structure–activity relationship, Pyruvate kinase, Small molecule, PKM2 and Enzyme are all subfields of Biochemistry research.
His Pyruvate kinase research is multidisciplinary, relying on both Phosphoenolpyruvate carboxykinase and Cell biology.
His study looks at the relationship between Stereochemistry and topics such as Receptor, which overlap with Endocrinology.
He most often published in these fields:
- Cancer research (30.98%)
- Pharmacology (16.56%)
- Biochemistry (15.64%)
What were the highlights of his more recent work (between 2019-2021)?
- Cancer research (30.98%)
- Kinase (9.51%)
- In vivo (7.06%)
In recent papers he was focusing on the following fields of study:
Craig J. Thomas mostly deals with Cancer research, Kinase, In vivo, Pyruvate kinase and Pharmacology.
Craig J. Thomas interconnects Cell culture, Protein kinase B, Cell growth, Transcription factor and PI3K/AKT/mTOR pathway in the investigation of issues within Cancer research.
His work on LYN as part of his general Kinase study is frequently connected to Cell Migration Assay, thereby bridging the divide between different branches of science.
His studies in In vivo integrate themes in fields like Sickle cell trait, Chronic pain, Renal cell carcinoma, Docetaxel and Hippocampus.
His Pyruvate kinase research is multidisciplinary, incorporating elements of PCK2 and Phosphoenolpyruvate carboxykinase.
His Pharmacology study combines topics in areas such as Antidepressant, Monoclonal antibody, Mood disorders and Ketamine.
Between 2019 and 2021, his most popular works were:
- O-GlcNAc regulates gene expression by controlling detained intron splicing. (19 citations)
- Pyruvate Kinase Controls Signal Strength in the Insulin Secretory Pathway (12 citations)
- Increased demand for NAD+ relative to ATP drives aerobic glycolysis (10 citations)
In his most recent research, the most cited papers focused on:
Craig J. Thomas spends much of his time researching Cancer research, Cell biology, Pyruvate kinase, Phosphoenolpyruvate carboxykinase and Kinase.
The study incorporates disciplines such as Viability assay, Malignant peripheral nerve sheath tumor and Cell growth in addition to Cancer research.
His study in Cell biology is interdisciplinary in nature, drawing from both Glycolysis, Metabolism, Oxidative phosphorylation and RNA-Seq.
His work deals with themes such as Allosteric regulation and Proto-oncogene tyrosine-protein kinase Src, which intersect with Glycolysis.
His Pyruvate kinase research incorporates elements of Insulin and Pancreatic islets.
Craig J. Thomas combines subjects such as Phenotype, Computational biology and Orders of magnitude with his study of Kinase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
